Where Does Akebia Therapeutics Inc (AKBA) Stock Fall in the Biotechnology Field After It Has Fallen -9.68% This Week?

A rating of 97 puts Akebia Therapeutics Inc (AKBA) near the top of the Biotechnology industry according to InvestorsObserver. Akebia Therapeutics Inc's score of 97 means it scores higher than 97% of stocks in the industry. Akebia Therapeutics Inc also received an overall rating of 79, putting it above 79% of all stocks. Biotechnology is ranked 75 out of the 148 industries.

AKBA has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on AKBA!

See Full AKBA Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Akebia Therapeutics Inc Stock Today?

Akebia Therapeutics Inc (AKBA) stock is down -5.08% while the S&P 500 has risen 0.19% as of 11:19 AM on Monday, Sep 25. AKBA is lower by -$0.06 from the previous closing price of $1.18 on volume of 493,304 shares. Over the past year the S&P 500 has risen 18.42% while AKBA has risen 261.29%. AKBA lost -$0.54 per share the over the last 12 months. Click Here to get the full Stock Report for Akebia Therapeutics Inc stock.